MedTrace Logo

Mother Milk as a Eye Drop & Premature Retinopathy

NCT04883931 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2022-03-16

No results posted yet for this study

Summary

The aim of this study is to investigate the effect of using breast milk as eye drops on ROP (Retinopathy of prematurity) disease observed in less then 32 weeks gestational age preterm babies.

Conditions

  • Retinopathy of Prematurity

Interventions

DRUG

Normal Saline

0.5 ml 0.9% normal saline will drop on both eyes twice in a day.

BIOLOGICAL

Breast milk

0.5 ml breast milk from all infant's own mother will drop both eyes twice in a day

Sponsors & Collaborators

  • Konya City Hospital

    collaborator OTHER

  • Konya Dr. Ali Kemal Belviranli Hospital for Obstetrics and Pediatrics

    collaborator UNKNOWN

  • Baskent University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2021-11-30
Completion
2022-01-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04883931 on ClinicalTrials.gov